Cooperative Agreement HPPWH100066

This federal Cooperative Agreement award, provided by the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based program (CFDA 93.940), aims to strengthen existing agreements and develop new strategies to re-engage people with HIV (PWH) who are not in care and outreach to those who are not virally suppressed in rural communities and municipalities in Puerto Rico. The $1,000,000 award to the Puerto Rico Department of Health (PRDOH) will...

This federal Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $186,319 to The Regents of the University of California, San Francisco (UCSF) to adapt and test an intervention to reduce HIV-related stigma among pregnant and postpartum women in sub-Saharan Africa. The key activities include: 1) Describing the stigma experiences and mental health impacts of women living with HIV during...

This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $381,487 to the University of Maryland, Baltimore (UMB) to assess the early implementation of long-acting injectable cabotegravir (CAB-LA) pre-exposure prophylaxis (PrEP) among adolescent girls and young women (AGYW) at high risk of HIV acquisition in Zambia. The key objectives are to: 1) Evaluate implementation determinants of CAB-LA...

The Puerto Rico Community Network for Clinical Services, Research and Health Advancement (PRCONCRA) Inc. was awarded a $450,000 Project Grant by the U.S. Department of Health and Human Services, Health Resources and Services Administration (HRSA) under the Ryan White HIV/AIDS Program HIV-Related Training and Technical Assistance (CFDA 93.145) federal grant program. The award, effective September 1, 2024 through November 30, 2025, will support comprehensive educational and capacity-building...

This Project Grant award from the U.S. Department of Health and Human Services HIV/AIDS Bureau provides $986,850.00 to the Cook County Health Bureau in Illinois to deliver coordinated, family-centered outpatient and ambulatory care services for low-income, uninsured, and medically underserved women, infants, children, and youth (WICY) living with HIV/AIDS. The funding supports the Coordinated Services and Access to Research for Women, Infants, Children, and Youth (CFDA 93.153) program, which...

This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) is funded through the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834). The $4,989,476 award to Community Education Group, Inc. will enable the organization's West Virginia Division (doing business as the National Women & HIV / Aids Project) to provide technical assistance, training, and capacity building support to health departments, community-based...

This $677,589 Project Grant award from the National Institutes of Health (NIH) Office of the Director's Trans-NIH Research Support program (CFDA 93.310) supports the development and pilot testing of a novel HIV prevention program targeting women experiencing incarceration. The "FIT for PrEP" (F4P) program aims to link these high-risk women to post-release pre-exposure prophylaxis (PrEP) services and address associated social determinants of health during community re-entry. Key aspects...

This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), aims to adapt and evaluate the effectiveness of the Comprehensive Adherence Resource and Empowerment Support (CARES) intervention to increase pre-exposure prophylaxis (PrEP) continuation and adherence among adolescent girls and young women in South Africa and Zimbabwe. The total funding amount is $710,187, with an award date of September 11, 2024 and an...

This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $702,000 to support a 3-year project aimed at optimizing the implementation of long-acting injectable pre-exposure prophylaxis (LAI-PrEP) for HIV prevention. The key objectives are to: 1) Identify barriers and facilitators to LAI-PrEP implementation, 2) Determine optimal implementation strategies in partnership with...

This federal Project Grant award of $709,872 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to develop and pilot test a couple-based intervention to address perinatal depression and improve adherence to prevention of mother-to-child transmission (PMTCT) of HIV in Malawi. The key objectives are to: 1) develop a couple-based intervention using problem-solving therapy and content on couple...